All In Biotech

NDA 019708 · B Braun

Potassium Chloride 0.22% In Sodium Chloride 0.9% In Plastic Container

Potassium Chloride, Sodium Chloride · Injection

Last checked: Nov 19, 2026Latest source record: Jan 17, 2026 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1989

Sep 29, 1989

Approved uses

1

Original approval plus efficacy supplements

Registered trials

9,299

2,122 Phase 3, 968 recruiting

FAERS reports

26

13 serious, 3 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Nov 13, 2026.

INDICATIONS AND USAGE Potassium Chloride in 0.9% Sodium Chloride Injection is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Sep 29, 1989 Original approval · Type 5 - New Formulation or New Manufacturer
6 products under this application
  • POTASSIUM CHLORIDE 0.22% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER · POTASSIUM CHLORIDE 220MG/100ML; SODIUM CHLORIDE 900MG/100ML · INJECTABLE, INJECTION · Discontinued
  • POTASSIUM CHLORIDE 0.11% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER · POTASSIUM CHLORIDE 110MG/100ML; SODIUM CHLORIDE 900MG/100ML · INJECTABLE, INJECTION · Discontinued
  • POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER · POTASSIUM CHLORIDE 37MG/100ML; SODIUM CHLORIDE 900MG/100ML · INJECTABLE, INJECTION · Discontinued
  • POTASSIUM CHLORIDE 0.3% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER · POTASSIUM CHLORIDE 300MG/100ML; SODIUM CHLORIDE 900MG/100ML · INJECTABLE, INJECTION · Discontinued
  • POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER · POTASSIUM CHLORIDE 150MG/100ML; SODIUM CHLORIDE 900MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • POTASSIUM CHLORIDE 0.075% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER · POTASSIUM CHLORIDE 75MG/100ML; SODIUM CHLORIDE 900MG/100ML · INJECTABLE, INJECTION · Discontinued

Clinical trials

Interventional ClinicalTrials.gov studies with "Chloride" as an intervention, any sponsor and status, largest first.

All 9,299 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • infusion site pain4
  • product label confusion4
  • vein disorder4
  • discomfort3
  • hypokalaemia3
  • product name confusion3
  • sepsis3
  • acute kidney injury2
  • death2
  • intercepted product selection error2
  • product expiration date issue2
  • product packaging confusion2

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
20121
20137
20142
20152
20161
20171
20191
20201
20215
20222
20231
20242

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 4,091 on PubMed

Sponsor: B Braun · Also marketed as Potassium Chloride 0.11% In Sodium Chloride 0.9% In Plastic Container, Potassium Chloride 0.037% In Sodium Chloride 0.9% In Plastic Container, Potassium Chloride 0.3% In Sodium Chloride 0.9% In Plastic Container, Potassium Chloride 0.15% In Sodium Chloride 0.9% In Plastic Container, Potassium Chloride 0.075% In Sodium Chloride 0.9% In Plastic Container

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.